
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Keyur Patel, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas and Connecticut.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Molecular Genetic Pathology, 2009 - 2010
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Hematopathology, 2008 - 2009
- N.H.L Municipal Medical CollegeClass of 1999
Certifications & Licensure
- TX State Medical License 2010 - 2025
- CT State Medical License 2008 - 2010
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Clinical Informatics
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature review.Karen Amelia Nahmod, Roberto N Miranda, Francisco Vega, Beenu Thakral, Naveen Pemmaraju
Leukemia & Lymphoma. 2025-04-01 - 3 citationsLong-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.Wei-Ying Jen, Jennifer Marvin-Peek, Hagop M Kantarjian, Yesid Alvarado, Gautam Borthakur
Cancer. 2025-01-01 - Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy.Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, Naifa L Busaidy, Priyanka Iyer
JCO Precision Oncology. 2025-01-01
Press Mentions
- Liquid Biopsy’s Promise and ComplexitiesMarch 25th, 2025
- Combination Therapy Shown as Effective for Higher-Risk DS/AML PatientsDecember 7th, 2014